Healthcare Services Group
Healthcare Services Group's revenue rose 7.1% to $1.8 billion in fiscal 2025. Its net margin was 3.2%, up from 2.3% a year earlier. Free cash flow was $139 million, up 468.8%. It paid out $62 million in dividends and buybacks, 44% of free cash flow. The diluted share count fell 1.3%.
Net margin is net income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Healthcare Services Group does
Healthcare Services Group provides housekeeping, laundry and dietary (food service) management to nursing homes and other healthcare facilities. It provides these services to its customers' facilities, mostly under full-service agreements in which it manages the employees on site and supplies certain supplies.
It has two reportable segments. Environmental Services, which handles cleaning, disinfecting and laundry, accounted for approximately 44.9% of consolidated revenues in 2025. Dietary, which handles food purchasing, meal preparation and dietitian services, represented approximately 55.1%.
Its customers are mainly in healthcare and rely on Medicare and Medicaid payments, so government payment rules affect them. Its agreements are usually cancellable by either side on 30 to 90 days' notice.
Its biggest risks, as it describes them
- Inflation and higher labor and supply costs, and relying on a few vendors for supplies.
- A few customers that make up a large part of its revenue.
- Customers that depend on Medicare and Medicaid payments, which could be cut.
- Customers' ability to pay, and the bad debts that can follow.
- Service agreements that either side can cancel on short notice.
Income statement
From fiscal 2016 to 2025, earnings per share fell 2.8% a year and net income 3.0% a year, while buybacks cut the share count by 1%.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 185 | 122 | 148 | 107 | 168 |
| Debt incl. finance leases | — | — | — | — | — |
| Net debt (negative means net cash) | — | — | — | — | — |
| Net debt to EBITDA | — | — | — | — | — |
| Debt to equity | — | — | — | — | — |
| Interest coverage | 48.3x | 16.8x | 7.8x | 9.2x | 41.4x |
| Current ratio | 2.9x | 2.7x | 2.6x | 2.9x | 3.4x |
| Quick ratio | 2.9x | 2.7x | 2.6x | 2.9x | 3.4x |
Cash flow
Projections
Project Healthcare Services Group's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
What Healthcare Services Group says to expect
- Full year: effective tax rate
The Company expects its full-year effective tax rate to be approximately 25.0%.
Insider trades
Over the 12 months between November 7, 2025 and November 6, 2026, no insider bought Healthcare Services Group shares on the open market, and 4 insiders sold $3.4 million, $54,158 of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Andrew KushEVP & Chief Operating Officer | Sold | 15,598 | $23.24 | $362,498 | Form 4 |
| Feb 26, 2026 | Andrew M BrophySVP & Chief Accounting Officer | Sold plan | 2,490 | $21.75 | $54,158 | Form 4 |
| Feb 18, 2026 | John Christopher SheaEVP & Chief Admin. Officer | Sold | 54,357 | $20.41 | $1.1 million | Form 4 |
| Feb 18, 2026 | Patrick J OrrEVP & Chief Revenue Officer | Sold | 45,500 | $20.54 | $934,570 | Form 4 |
| Feb 18, 2026 | Patrick J OrrEVP & Chief Revenue Officer | Sold | 44,615 | $20.53 | $915,835 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | — | — | — |
| Rule of 40 | 1.2% | 4.1% | 14.7% |
| Altman Z'' | 5.66 | 6.12 | 6.99 |
| Accruals ratio | −0.7% | 1.1% | −10.8% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Fail | Pass |
| Cash from operations exceeds net income | Pass | Fail | Pass |
| Debt fell relative to assets | — | — | — |
| Current ratio rose | Fail | Pass | Pass |
| Share count didn't rise | Pass | Pass | Pass |
| Gross margin rose | Pass | Pass | Fail |
| Revenue rose relative to assets | Pass | Fail | Pass |
| F-score | — | — | — |
Compare
Put Healthcare Services Group side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Healthcare Services Group | FY25 | 7.1% | — | 7.6% | — | — | — | |
| Casella Waste Systems | FY25 | 17.9% | 3.5% | 4.6% | 1.6% | 2.8x | 4 | Compare |
| GEO Group | FY25 | 8.6% | 9.8% | −4.8% | 6.3% | 4.1x | 6 | Compare |
| Rollins | FY25 | 11.0% | 19.3% | 17.3% | 31.0% | 0.6x | 6 | Compare |
| Veralto | FY25 | 6.0% | 23.2% | 18.4% | 28.1% | 0.5x | 6 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 1,563 | 1,861 | 2,003 | 1,841 | 1,760 | 1,642 | 1,690 | 1,671 | 1,716 | 1,837 |
| Revenue growth | — | 19.1% | 7.6% | −8.1% | −4.4% | −6.7% | 2.9% | −1.1% | 2.6% | 7.1% |
| Gross profit | 223 | 251 | 234 | 228 | 268 | 231 | 193 | 215 | 228 | 239 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — | — | — |
| Net income | 77 | 88 | 84 | 65 | 99 | 48 | 34 | 38 | 40 | 59 |
| Diluted EPS (US$) | 1.05 | 1.19 | 1.12 | 0.87 | 1.32 | 0.65 | 0.46 | 0.52 | 0.53 | 0.81 |
| Diluted shares (millions) | 74 | 74 | 75 | 75 | 75 | 75 | 74 | 74 | 74 | 73 |
| Cash flow | ||||||||||
| Cash from operations | 41 | 8 | 80 | 94 | 217 | 37 | −8 | 44 | 31 | 145 |
| Capital expenditure | 5 | 5 | 5 | 4 | 4 | 6 | 5 | 5 | 6 | 6 |
| Free cash flow | 36 | 2 | 75 | 89 | 213 | 31 | −13 | 38 | 24 | 139 |
| Dividends paid | 53 | 55 | 57 | 59 | 61 | 62 | 63 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 22 | 0 | 11 | 5 | 62 |
| Acquisitions | 0 | 5 | 0 | 0 | 0 | 24 | 0 | 0 | 0 | 7 |
| Stock-based compensation | 4 | 6 | 6 | 7 | 8 | 9 | 9 | 9 | 9 | 12 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 92 | 83 | 102 | 118 | 264 | 185 | 122 | 148 | 107 | 168 |
| Debt incl. finance leases | — | — | — | — | — | — | — | — | — | — |
| Total assets | 528 | 676 | 693 | 723 | 785 | 780 | 721 | 791 | 803 | 794 |
| Total liabilities | 190 | 276 | 252 | 262 | 315 | 332 | 303 | 334 | 303 | 284 |
| Shareholders' equity | 339 | 400 | 441 | 460 | 470 | 445 | 418 | 457 | 500 | 510 |
| Margins and ratios | ||||||||||
| Gross margin | 14.3% | 13.5% | 11.7% | 12.4% | 15.2% | 14.0% | 11.4% | 12.8% | 13.3% | 13.0% |
| Operating margin | — | — | — | — | — | — | — | — | — | — |
| Net margin | 5.0% | 4.7% | 4.2% | 3.5% | 5.6% | 3.0% | 2.0% | 2.3% | 2.3% | 3.2% |
| Free cash flow margin | 2.3% | 0.1% | 3.8% | 4.8% | 12.1% | 1.9% | −0.8% | 2.3% | 1.4% | 7.6% |
| Rule of 40 (growth + FCF margin) | — | 19.2% | 11.3% | −3.2% | 7.7% | −4.8% | 2.1% | 1.2% | 4.1% | 14.7% |
| Return on capital | — | — | — | — | — | — | — | — | — | — |
| Return on equity | 24.4% | 23.9% | 19.9% | 14.3% | 21.2% | 10.6% | 7.9% | 8.8% | 8.2% | 11.7% |
| Return on assets | 15.3% | 14.7% | 12.2% | 9.1% | 13.1% | 6.2% | 4.6% | 5.1% | 5.0% | 7.4% |
| Net debt to EBITDA | — | — | — | — | — | — | — | — | — | — |